Supporting excellence in
patient care, research and education.

Cedars Inaugural Gala

Activity Date:
6 December 2018

Time of the event:
Cocktail 6:30 p.m. - Dinner 7:30 p.m.

Description of the activity:



The Cedars Cancer Centre and The Cedars Cancer Foundation are proud to invite you to their Inaugural Gala “At the Leading Edge”, that will be held on Thursday, December 6, 2018 under the Honorary Chairmanship of Louis Vachon, Chief Executive Officer, National Bank of Canada.

This prestigious gala will shine a spotlight on the exciting developments in the fight against cancer, while paying special tribute to the world-class professionals of the Cedars Cancer Centre at the McGill University Health Centre.

These talented women and men relentlessly push the boundaries of knowledge and ultra-specialized practice throughout the international scientific and healthcare community. They are involved not only in our hospitals but also in national and international organizations. They embrace the pursuit of excellence and innovation, despite the myriad of challenges.

They astonish and inspire us. They also motivate us to increase awareness and raise vital funds to support their cutting-edge efforts, which is why we are inviting you to join us for what can only be described as an essential collective effort.

With the community’s vision and generosity, and most importantly with you in attendance, we are confident that we can help our fine teams of cancer professionals be “At the Leading Edge” of cancer care.  

We look forward to honouring our healthcare professionals with you on December 6th.
 
 
SPONSORSHIP & TABLE OPPORTUNITIES
 
Through your sponsorship support, you will help the Cedars Cancer Centre achieve its mission of changing the landscape of cancer care, research and education in an effort to end the pain and suffering that cancer causes.


 
 

ABOUT THE CANCER CARE MISSION OF THE MUHC
With the opening of the Cedars Cancer Centre in 2015, a new era of comprehensive patient-centered cancer care was launched in Montreal at the new McGill University Health Centre (MUHC). Integrating almost all cancer care under one same roof, the clinic structure is based on multi-disciplinary patient care.

This high volume complex care environment receives approximately 175,000 visits annually, and treats approximately 800 patients per day in Medical-Oncology, Hematologic Oncology, Radiation-Oncology, Surgical-Oncology and Palliative and Supportive Care. It delivers a harmonious blend of cutting-edge technology and compassionate patient-centered care. This allows our medical professionals to continue to be pioneers in cancer diagnosis and innovative treatment, inspire the next generation of healthcare professionals, and push the boundaries of scientific discovery, while providing patients with the highest level of specialized care and support in one location, designed to optimize the patient experience.


ABOUT THE CANCER AXIS OF THE RESEARCH INSTITUTE OF THE MUHC
The Cancer Research Program (CRP) benefits from new state-of-the-art facilities to conduct basic research at the Centre for Translational Biology, clinical cancer research at the Centre for Innovative Medicine, and evaluative cancer research at the Centre for Outcomes Research and Evaluation. Activities are supported by several newly enhanced technology platforms at the Glen site, including the Immunophenotyping, Histopathology, Biobank, Proteomics, Microscopy, Molecular Imaging, Small Animal Imaging Labs and Drug Discovery platforms.

The integration of basic, clinical and evaluative science has resulted in a new program that is able to pursue precision care research in collaboration with the Cedars Cancer Centre of the MUHC at the Glen. The CRP focuses on the mechanisms of etiology (hereditary predisposition), spread (metastasis) and progression of disease, with current studies in such domains as the identification of new markers and therapeutic targets, gene therapy, tumour suppressor genes, angiogenesis and radiosensitivity.
 

ABOUT THE CEDARS CANCER FOUNDATION
Easing the pain and suffering that cancer causes has guided the Cedars Cancer Foundation since 1966. Decade after decade, we continue to breathe life into our vision by galvanizing our community of donors around our mission, which is to improve the health and well-being of pediatric, young adult and adult cancer patients, and their families, throughout and beyond treatment. We do so by leading philanthropic initiatives that support excellence and innovation in clinical care, research, education and supportive care services.

Proceeds raised through events, corporate and individual donations, major gifts, planned giving, and dedicated funds are directed to:
  • Exceptional care – prevention, diagnosis and treatment, post treatment, supportive care and palliative care – for the youngest pediatric patients to adolescents and adults
  • Pediatric Hemato-Oncology on Sarah’s floor at the Montreal Children’s Hospital supported by Sarah’s Fund for Cedars
  • State-of-the-art equipment
  • Patient-support programs such as Cedars CanSupport (www.cansupport.ca), The Cedars Breast Program, Psychosocial Oncology, etc.
  • Building and sustaining awareness of cancer-related issues
  • Investments in cancer research, patient education and professional training

The Cedars Cancer Centre
In 2014, the McGill University Health Centre (MUHC) recognized the past and future contributions of the Cedars Cancer Foundation to its institution by naming its brand new cancer centre at the Glen site the Cedars Cancer Centre. Inaugurated in 2015, it has become in a few short years an integrated hub for cancer treatment in Montreal. Future readiness requires the brightest people, the best equipment and the passion to innovate to remain a centre of excellence in cancer care, research and education.
 

The Rossy Cancer Network
The Cedars Cancer Foundation, a partner of the Rossy Cancer Network, recognizes that emerging needs require significant and sustained investment. Cancer survivorship is one example. Long-term survival of many common cancers has doubled in the last forty years. As a result, expected and unexpected side effects of treatment need to be better understood and managed. Together with our colleagues at the MUHC, Jewish General Hospital, St Mary’s Hospital Center and McGill University, we are committed to maintaining a leadership position by continually improving the quality of care and patient satisfaction, increasing the survival rate, and reducing the burden of cancer across the continuum of treatment, from diagnosis to treatment, to supportive care and palliative care.
 

The Cedars Oncology Supportive Care Centre
As per the best practices in integrated cancer centres, Cedars is helping to establish the Cedars Oncology Supportive Care Centre in 2019. The centre will consolidate and enhance existing programs and services under one roof and assure the community has access to complementary services that support clinical care and healing. The objective is to reduce symptoms, improve survival rates and meet the psychosocial needs of patients as they move from diagnosis to treatment, survival and bereavement.

 
 
LEADERSHIP


 
If you are unable to attend, please consider making a donation to
Cedars Cancer Foundation.

 



For more information, please contact
stephanie.claxton@cedarscancer.ca
514-656-6662 ext. 227



Photo are being taken at this event and may appear in cedars.ca and affiliated social media
 


Event location:
Plaza Centre-Ville
777 Boulevard Robert-Bourassa
Montréal, QC H3C 3Z7

Price:
Individual ticket $1,000.00
Table (10 guests) $10,000.00



Share
© Cedars Cancer Foundation
1310 Greene Avenue, Suite 520, Westmount, Quebec H3Z 2B2
Telephone: (514) 656-6662   Fax: (514) 303-1288  
Email: email address  CRA No. 10520-2501-RR-0001     Disclaimer | Privacy

Log In